IP Library Granted Patent US 12,515,051
Granted Patent B2
US 12,515,051 · App. 18/188,339 · Granted Jan 6, 2026

Programming of neural stimulation therapy

Inventors: Dean Michael Karantonis (Artarmon, AU); Daniel John Parker (Artarmon, AU); Ian Cameron Gould (Artarmon, AU)
Assignee: Saluda Medical Pty Ltd
A61N1/36139A61B5/294A61N1/36157G06F17/18A61N1/37235
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,515,051
App. No.
18/188,339
Granted
Jan 6, 2026
Kind
B2
Abstract

Disclosed is a method of computing a probability distribution of the suitability of measurement electrode configurations for a neuromodulation device. The method comprises: computing the probability distribution of suitability of measurement electrode configurations from: a predetermined stimulus program vector of the neuromodulation device; and prior patient data. Also disclosed is an automated method of setting a measurement electrode configuration for a neuromodulation device configured to deliver a neural stimulus to a neural pathway of a patient. The method comprises: obtaining an initial measurement electrode configuration for a predetermined stimulus program vector from a prior probability distribution of suitability of measurement electrode configurations; delivering a plurality of neural stimuli of different stimulus intensities to the neural pathway according to the stimulus program vector; measuring intensities of neural responses evoked by the neural stimuli using a current measurement electrode configuration; computing one or more quality measures of the evoked neural responses using the measured neural response intensities and the respective stimulus intensities; refining the probability distribution of suitability of measurement electrode configurations using the one or more quality measures; and obtaining a new measurement electrode configuration for the predetermined stimulus program vector using the refined probability distribution of suitability of measurement electrode configurations.

Claims (29)

1 . A neuromodulation system comprising:

a neuromodulation device for controllably delivering a neural stimulus, the neuromodulation device comprising:

a stimulus source configured to provide a neural stimulus to be delivered to a neural pathway of a patient in order to evoke a neural response on the neural pathway;

measurement circuitry configured to process a signal sensed at a measurement electrode configuration subsequent to the delivered neural stimulus, the sensed signal including an evoked neural response; and

a control unit configured to:

control the stimulus source to provide the neural stimulus according to a predetermined stimulus program vector; and

measure an intensity of the evoked neural response in the sensed signal using a measurement parameter vector; and

a processor configured to:

obtain an initial measurement electrode configuration for the predetermined stimulus program vector from a prior probability distribution of suitability of measurement electrode configurations;

instruct the control unit to control the stimulus source to provide a plurality of neural stimuli of different stimulus intensities to the neural pathway according to the predetermined stimulus program vector;

measure intensities of neural responses evoked by the neural stimuli and sensed via a current measurement electrode configuration;

compute one or more quality measures of the evoked neural responses using the measured neural response intensities and the respective stimulus intensities;

refine the prior probability distribution of suitability of measurement electrode configurations using the one or more quality measures; and

obtain a new measurement electrode configuration for the predetermined stimulus program vector from the refined prior probability distribution of suitability of measurement electrode configurations.

2 . The neuromodulation system of claim 1 , wherein the processor is further configured to repeat the instructing, measuring, computing, refining, and obtaining until a stopping criterion is reached.

3 . The neuromodulation system of claim 1 , wherein the processor is further configured to compute the prior probability distribution of suitability of measurement electrode configurations from:

the predetermined stimulus program vector of the neuromodulation device; and

prior patient data.

4 . The neuromodulation system of claim 1 , wherein the processor is further configured to:

obtain an initial measurement parameter vector for the predetermined stimulus program vector and the initial measurement electrode configuration from one of a plurality of prior probability distributions of suitability of measurement parameters corresponding to the initial measurement electrode configuration and the stimulus program vector;

measure the intensities of the neural responses evoked by the neural stimuli and sensed via the initial measurement electrode configuration using the initial measurement parameter vector; and

refine the prior probability distribution of suitability of measurement parameters corresponding to the initial measurement electrode configuration using the one or more quality measures.

5 . The neuromodulation system of claim 4 , wherein the processor is further configured to obtain a new measurement parameter vector for the neuromodulation device using the refined probability distribution of suitability of measurement parameters corresponding to the new measurement electrode configuration.

6 . The neuromodulation system of claim 4 , wherein the processor is further configured to compute the plurality of probability distributions of suitability of measurement parameters for respective measurement electrode configurations using:

the predetermined stimulus program vector of the neuromodulation device; and

prior patient data.

7 . The neuromodulation system of claim 1 , further comprising an external computing device in communication with the neuromodulation device.

8 . The neuromodulation system of claim 7 , wherein the processor forms part of the external computing device.

9 . The neuromodulation system of claim 1 , wherein the processor forms part of the neuromodulation device.

Assignments (2)
SECURITY INTEREST Recorded Mar 14, 2025
From: SALUDA MEDICAL PTY LTD
To: PERCEPTIVE CREDIT HOLDINGS IV, LP
Reel/Frame 070518/0710 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 18, 2023
From: KARANTONIS, DEAN MICHAEL; PARKER, DANIEL JOHN; GOULD, IAN CAMERON
To: SALUDA MEDICAL PTY LTD
Reel/Frame 064304/0753 →
Priority Claims (1)
AU 2022900717 · Mar 22, 2022 · national
Continuity (1)
Related Publication 20230321443A1 · Oct 12, 2023
References Cited (18)
US 6931281B2 · Bradley et al. · 2005 [cited by applicant]
US 20230241376A1 · Single et al. · 2023 [cited by applicant]
US 20230277852A1 · Karantonis · 2023 [cited by applicant]
US 20230310864A1 · Parker · 2023 [cited by applicant]
WO WO2012155183 · 2012 [cited by applicant]
WO WO2012155185A1 · 2012 [cited by applicant]
WO WO2012155188 · 2012 [cited by applicant]
WO WO2015074121 · 2015 [cited by applicant]
WO WO2015074121A1 · 2015 [cited by applicant]
WO WO2020101853A1 · 2020 [cited by applicant]
WO WO2021007615A1 · 2021 [cited by applicant]
WO WO2021158310A1 · 2021 [cited by applicant]
WO WO2022182611A1 · 2022 [cited by applicant]
WO WO2022183172A1 · 2022 [cited by applicant]
WO WO2022245970A1 · 2022 [cited by applicant]
WO WO2023064081A1 · 2023 [cited by applicant]
WO WO2023115132 · 2023 [cited by applicant]
WO WO2023150020A1 · 2023 [cited by applicant]